We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medical Properties (MPW) Surpasses Market Returns: Some Facts Worth Knowing
Read MoreHide Full Article
Medical Properties (MPW - Free Report) ended the recent trading session at $5.08, demonstrating a +1.6% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of 0.19% for the day. Meanwhile, the Dow gained 0.66%, and the Nasdaq, a tech-heavy index, lost 0.03%.
Shares of the health care real estate investment trust have depreciated by 10.87% over the course of the past month, underperforming the Finance sector's gain of 2.08%, and the S&P 500's gain of 0.54%.
Investors will be eagerly watching for the performance of Medical Properties in its upcoming earnings disclosure. The company's upcoming EPS is projected at $0.15, signifying a 16.67% drop compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $242.96 million, reflecting a 4.79% rise from the equivalent quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.55 per share and revenue of $944.64 million. These totals would mark changes of -31.25% and 0%, respectively, from last year.
Investors might also notice recent changes to analyst estimates for Medical Properties. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, there's been a 2.96% fall in the Zacks Consensus EPS estimate. Medical Properties is holding a Zacks Rank of #3 (Hold) right now.
With respect to valuation, Medical Properties is currently being traded at a Forward P/E ratio of 7.62. This represents a discount compared to its industry average Forward P/E of 11.01.
The REIT and Equity Trust - Other industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 160, positioning it in the bottom 35% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Medical Properties (MPW) Surpasses Market Returns: Some Facts Worth Knowing
Medical Properties (MPW - Free Report) ended the recent trading session at $5.08, demonstrating a +1.6% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of 0.19% for the day. Meanwhile, the Dow gained 0.66%, and the Nasdaq, a tech-heavy index, lost 0.03%.
Shares of the health care real estate investment trust have depreciated by 10.87% over the course of the past month, underperforming the Finance sector's gain of 2.08%, and the S&P 500's gain of 0.54%.
Investors will be eagerly watching for the performance of Medical Properties in its upcoming earnings disclosure. The company's upcoming EPS is projected at $0.15, signifying a 16.67% drop compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $242.96 million, reflecting a 4.79% rise from the equivalent quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.55 per share and revenue of $944.64 million. These totals would mark changes of -31.25% and 0%, respectively, from last year.
Investors might also notice recent changes to analyst estimates for Medical Properties. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, there's been a 2.96% fall in the Zacks Consensus EPS estimate. Medical Properties is holding a Zacks Rank of #3 (Hold) right now.
With respect to valuation, Medical Properties is currently being traded at a Forward P/E ratio of 7.62. This represents a discount compared to its industry average Forward P/E of 11.01.
The REIT and Equity Trust - Other industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 160, positioning it in the bottom 35% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.